Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q68D85
UPID:
NR3L1_HUMAN
Alternative names:
B7 homolog 6
Alternative UPACC:
Q68D85; Q7Z3M6
Background:
Natural cytotoxicity triggering receptor 3 ligand 1, also known as B7 homolog 6, plays a pivotal role in immune surveillance by triggering NCR3-dependent natural killer cell activation. This process is crucial for the identification and elimination of tumor cells and pathogens.
Therapeutic significance:
Understanding the role of Natural cytotoxicity triggering receptor 3 ligand 1 could open doors to potential therapeutic strategies. Its ability to activate natural killer cells suggests its potential in cancer immunotherapy and infectious disease management.